Phase IV Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients

Trial Profile

Phase IV Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2013

At a glance

  • Drugs Atazanavir (Primary) ; Ritonavir (Primary) ; Lamivudine; Stavudine
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2009 Week-96 body composition data published in Clinical Infectious Diseases.
    • 25 Jul 2007 Results to 96 weeks were reported at IAS.
    • 28 Feb 2007 Interim results at 48 weeks have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top